Source:http://linkedlifedata.com/resource/pubmed/id/10796640
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2000-7-6
|
| pubmed:abstractText |
Olanzapine is an atypical antipsychotic that is reported to be effective without producing the disabling extrapyramidal side effects associated with the older, typical antipsychotic drugs.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1469-493X
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
CD001359
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading | |
| pubmed:year |
2000
|
| pubmed:articleTitle |
Olanzapine for schizophrenia.
|
| pubmed:affiliation |
Developmental Disabilities Division, St Andrew's Hospital, Billing Rd, Northampton, Northamptonshire, UK, NN1 5DG. lornaduggan@yahoo.co.uk
|
| pubmed:publicationType |
Journal Article,
Review
|